AnalystsNavann TyNavann Ty's Stock Forecasts
AnalystsNavann Ty
Analyst Ranking
Bottom 19%
#4315 out of 5293 analysts
Average Return
-4.52%
Win Rate
75%6 out of 8
Risk vs Reward
Poor
Good
Navann Ty's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Horizon Therapeutics Public Ltd CoHZNP | +47.52% | $73.33 | $108.18 | 2020-08-27 - 2021-08-26 | Strong Buy |
Horizon Therapeutics Public Ltd CoHZNP | +20.69% | $88.15 | $106.39 | 2021-03-18 - 2022-03-17 | Strong Buy |
Jazz Pharmaceuticals PLCJAZZ | +8.07% | $128.08 | $138.41 | 2021-10-05 - 2022-10-04 | Strong Buy |
Organon & CoOGN | +7.25% | $29.80 | $31.96 | 2021-07-23 - 2022-07-22 | Strong Buy |
Cooper Companies IncCOO | +2.74% | $66.79 | $68.62 | 2026-06-08 - 2026-06-09 | Buy |
Navann Ty Analyst Color
Get additional color on Navann Ty's coverage of popular stocks
Navann Ty's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Cooper Companies IncCOO | 1 | Buy | $92.00 | +34.07% | Maintains | 2 days ago |
Medline IncMDLN | 1 | Hold | $40.00 | +11.08% | Maintains | a month ago |
Organon & CoOGN | 3 | Hold | $14.00 | +4.48% | Downgrades | a month ago |
Revance Therapeutics IncRVNC | 1 | Hold | $20.00 | N/A | Upgrades | 3 years ago |
Kenvue IncKVUE | 1 | Hold | $28.00 | N/A | Initiates Coverage On | 3 years ago |
Alkermes PLCALKS | 2 | Hold | $26.00 | N/A | Maintains | 4 years ago |
Viatris IncVTRS | 2 | Hold | $11.00 | N/A | Maintains | 4 years ago |
Endo International PLCENDPQ | 1 | Strong Buy | $6.00 | N/A | Maintains | 4 years ago |
Zoetis IncZTS | 2 | Hold | $232.00 | N/A | Maintains | 4 years ago |
Jazz Pharmaceuticals PLCJAZZ | 1 | Strong Buy | $200.00 | N/A | Initiates Coverage On | 5 years ago |
Horizon Therapeutics Public Ltd CoHZNP | 3 | Strong Buy | $121.00 | N/A | Maintains | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.